Comerica Bank Biotechnology

Comerica Bank

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
RVNC Revance Therapeutics, Inc.	$212M	$1,000 0.0% of portfolio	426	Q2 2024 Reduced 90.05%
THRD Third Harmonic Bio, Inc.	$139M	$1,000 0.0% of portfolio	115	Q4 2024 New
VRDN Viridian Therapeutics, Inc.\De	$619M	$1,000 0.0% of portfolio	65	Q3 2024 Added 8.33%
FDMT 4 D Molecular Therapeutics, Inc.	$147M	$0 0.0% of portfolio	77	Q4 2024 New
ALEC Alector, Inc.	$135M	$0 0.0% of portfolio	21	Q3 2023 New
BMEA Biomea Fusion, Inc.	$84.6M	$0 0.0% of portfolio	20	Q4 2024 New
FATE Fate Therapeutics Inc	$109M	$0 0.0% of portfolio	147	Q4 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$132M	$0 0.0% of portfolio	122	Q4 2024 New
LYRA Lyra Therapeutics, Inc.	$6.68M	$0 0.0% of portfolio	1,159	Q3 2023 New
MGNX Macrogenics Inc	$151M	$0 0.0% of portfolio	44	Q4 2024 New
RLAY Relay Therapeutics, Inc.	$410M	$0 0.0% of portfolio	35	Q4 2024 New
SAGE Sage Therapeutics, Inc.	$434M	$0 0.0% of portfolio	120	Q4 2024 Added 1,400.0%
SMMT Summit Therapeutics Inc.	$4.16B	$0 0.0% of portfolio	22	Q4 2024 New
STRO Sutro Biopharma, Inc.	$82.9M	$0 0.0% of portfolio	49	Q1 2024 Reduced 73.8%
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	165	Q4 2024 New

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.